US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

NDRA

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NDRA

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
20/05/2024	07:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
20/05/2024	07:00	Business Wire	ENDRA Provides Update Following In-person Meeting with FDA	NASDAQ:NDRA	ENDRA Life Sciences Inc
14/05/2024	15:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
14/05/2024	15:05	Business Wire	ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
10/05/2024	16:17	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NDRA	ENDRA Life Sciences Inc
07/05/2024	07:00	Business Wire	ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024	NASDAQ:NDRA	ENDRA Life Sciences Inc
02/05/2024	07:00	Business Wire	ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
28/03/2024	15:05	Business Wire	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
21/03/2024	07:00	Business Wire	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024	NASDAQ:NDRA	ENDRA Life Sciences Inc
27/02/2024	07:00	Business Wire	ENDRA Life Sciences Installs First TAEUS System in the UK	NASDAQ:NDRA	ENDRA Life Sciences Inc
23/02/2024	16:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NDRA	ENDRA Life Sciences Inc
21/02/2024	07:00	Business Wire	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System	NASDAQ:NDRA	ENDRA Life Sciences Inc
14/02/2024	07:30	Business Wire	ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe	NASDAQ:NDRA	ENDRA Life Sciences Inc
29/12/2023	16:07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
29/11/2023	07:00	Business Wire	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology	NASDAQ:NDRA	ENDRA Life Sciences Inc
27/11/2023	07:00	Business Wire	ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference	NASDAQ:NDRA	ENDRA Life Sciences Inc
14/11/2023	15:05	Business Wire	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
08/11/2023	07:00	Business Wire	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
07/11/2023	15:05	Business Wire	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
06/11/2023	07:00	Business Wire	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
07/09/2023	07:00	Business Wire	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
30/08/2023	07:00	Business Wire	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA	NASDAQ:NDRA	ENDRA Life Sciences Inc
23/08/2023	07:00	Business Wire	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
14/08/2023	15:53	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
14/08/2023	15:05	Business Wire	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
14/08/2023	12:30	Business Wire	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA	NASDAQ:NDRA	ENDRA Life Sciences Inc
01/08/2023	07:00	Business Wire	ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
25/07/2023	15:03	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NDRA	ENDRA Life Sciences Inc
06/07/2023	15:45	Business Wire	ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
07/06/2023	07:00	Business Wire	Study Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc

Showing the most relevant articles for your search:NASDAQ:NDRA

1 2 3 4 Próxima >

JP Morgan Chase

Gold vs US Dollar

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Health Care Select Sector

American Express

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones